axonics modulation tech stock price

by Juana Kuvalis Published 3 years ago Updated 2 years ago

What are analysts'1 year price targets for axonics modulation technologies'stock?

5 analysts have issued 1 year price objectives for Axonics Modulation Technologies' shares. Their predictions range from $14.92 to $47.00. On average, they expect Axonics Modulation Technologies' stock price to reach $35.5840 in the next year.

How much of axonics'stock are insiders selling?

In the past three months, Axonics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $302,400.00 in company stock. Only 2.59% of the stock of Axonics is held by insiders.

Is axonics (AXS) a good buy on Wall Street?

Axonics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings. According to analysts' consensus price target of $73.33, Axonics has a forecasted upside of 31.0% from its current price of $56.00.

When is axonics'next quarterly earnings announcement?

Axonics is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022. View our earnings forecast for Axonics. How were Axonics' earnings last quarter? Axonics, Inc. (NASDAQ:AXNX) posted its quarterly earnings data on Thursday, November, 4th.

Should I buy or sell Axonics stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Axonics in the last twelve months. There are currently 7...

What is Axonics' stock price forecast for 2022?

7 equities research analysts have issued 12-month price objectives for Axonics' shares. Their forecasts range from $62.00 to $79.00. On average, th...

How has Axonics' stock price performed in 2022?

Axonics' stock was trading at $56.00 on January 1st, 2022. Since then, AXNX stock has decreased by 4.0% and is now trading at $53.74. View the bes...

When is Axonics' next earnings date?

Axonics is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for Axonics .

How were Axonics' earnings last quarter?

Axonics, Inc. (NASDAQ:AXNX) posted its quarterly earnings results on Thursday, May, 5th. The company reported ($0.50) earnings per share (EPS) for...

What guidance has Axonics issued on next quarter's earnings?

Axonics issued an update on its FY 2022 earnings guidance on Monday, May, 30th. The company provided earnings per share (EPS) guidance of for the p...

Who are Axonics' key executives?

Axonics' management team includes the following people: Mr. Raymond W. Cohen , CEO & Director (Age 63, Pay $1.34M) ( LinkedIn Profile ) Mr. Dann...

What is Raymond W. Cohen's approval rating as Axonics' CEO?

12 employees have rated Axonics CEO Raymond W. Cohen on Glassdoor.com . Raymond W. Cohen has an approval rating of 89% among Axonics' employees.

Who are some of Axonics' key competitors?

Some companies that are related to Axonics include NovoCure (NVCR) , ShockWave Medical (SWAV) , Globus Medical (GMED) , Inspire Medical Systems...

Key Data Points

Environmental, Social, and Governance Rating

Primary metrics and data points about Axonics Modulation Technlogs INC.

Earnings Preview: Axonics Modulation Technologies (AXNX) Q4 Earnings Expected to Decline

"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.

Omnicell (OMCL) Lags Q4 Earnings Estimates

Axonics (AXNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

C WorldWide Group Holding A Buys Adobe Inc, Align Technology Inc, NovoCure, Sells Visa Inc, ..

Omnicell (OMCL) delivered earnings and revenue surprises of -3.16% and 0.30%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Penn Series SMID Cap Growth Fund Buys Vail Resorts Inc, Workiva Inc, Core & Main Inc, Sells ..

Investment company C WorldWide Group Holding A (Current Portfolio) buys Adobe Inc, Align Technology Inc, NovoCure, Axonics Inc, Exact Sciences Corp, sells Visa Inc, DexCom Inc, Quidel Corp, Xylem Inc, Fidelity National Information Services Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, C WorldWide Group Holding A..

How much does Axonics make?

Investment company Penn Series SMID Cap Growth Fund (Current Portfolio) buys Vail Resorts Inc, Workiva Inc, Core & Main Inc, Axonics Inc, Ameresco Inc, sells Zendesk Inc, Bio-Techne Corp, 10x Genomics Inc, Molina Healthcare Inc, Azenta Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Penn Series SMID Cap Growth Fund..

Where is Axonics located?

Axonics has a market capitalization of $2.78 billion and generates $111.54 million in revenue each year. The company earns $-54,920,000.00 in net income (profit) each year or ($1.48) on an earnings per share basis.

What is the axonics symbol?

Axonics' mailing address is 26 TECHNOLOGY DRIVE, IRVINE CA, 92618. The company can be reached via phone at (866) 722-5738, via email at [email protected], or via fax at 949-396-6321.

What is the P/E ratio of Axonics?

Axonics trades on the NASDAQ under the ticker symbol "AXNX."

Is Axonics a buy?

The P/E ratio of Axonics is -33.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Transparency is our policy. Learn how it impacts everything we do

Axonics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.

How we make money

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

How we use your personal data

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.

How we approach editorial content

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Axonics Modulation Technologies Valuation & Funding

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.

Axonics Modulation Technologies Cap Table

This information is available in the PitchBook Platform. To explore Axonics Modulation Technologies‘s full profile, request access.

Axonics Modulation Technologies Comparisons